Director dealings: TUI, Oxford Biomedica board members linked to buys
TUI AG Reg Shs (DI)
490.20p
09:45 30/11/23
TUI was among those on the list of director buys on Wednesday after its chief executive officer purchased almost 50,000 shares.
FTSE 250
18,365.19
09:45 30/11/23
FTSE 350
4,096.73
09:45 30/11/23
FTSE All-Share
4,055.60
09:45 30/11/23
FTSE Small Cap
6,051.22
09:45 30/11/23
Oxford Biomedica
168.00p
09:44 30/11/23
Pharmaceuticals & Biotechnology
19,502.35
09:45 30/11/23
Travel & Leisure
6,608.63
09:45 30/11/23
The travel giant said Sebastian Ebel picked up 49,900 shares on 26 September in a single transaction outside a trading venue.
Ebel paid €4.99 for each share, valuing the transaction at a total of €224,325.21 (£194,816.35).
Elsewhere, Oxford Biomedica disclosed a purchase linked to one of its non-executive directors.
The company said Sandra Juliet Ferera Hayden bought 12,000 shares on 26 September in a single transaction on the London Stock Exchange.
Hayden paid 293.5p for each share, valuing the purchase at £35,220.00.
In its disclosure, Oxford Biomedica said Sandra Hayden is a person closely associated with non-executive director Michael Hayden.
At 1304 BST, shares in TUI were up 3.39% in London at 451.6p, while those in Oxford Biomedica were 1.72% weaker at 286.5p.
Reporting by Josh White for Sharecast.com.